Rabab S. Hamad

616 total citations
52 papers, 357 citations indexed

About

Rabab S. Hamad is a scholar working on Molecular Biology, Epidemiology and Nutrition and Dietetics. According to data from OpenAlex, Rabab S. Hamad has authored 52 papers receiving a total of 357 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 6 papers in Epidemiology and 6 papers in Nutrition and Dietetics. Recurrent topics in Rabab S. Hamad's work include Sirtuins and Resveratrol in Medicine (5 papers), Genomics, phytochemicals, and oxidative stress (4 papers) and Parasites and Host Interactions (4 papers). Rabab S. Hamad is often cited by papers focused on Sirtuins and Resveratrol in Medicine (5 papers), Genomics, phytochemicals, and oxidative stress (4 papers) and Parasites and Host Interactions (4 papers). Rabab S. Hamad collaborates with scholars based in Egypt, Saudi Arabia and Romania. Rabab S. Hamad's co-authors include Sameh Saber, Elsayed A. Elmorsy, Mustafa Ahmed Abdel‐Reheim, Attalla F. El‐kott, Hayder M. Al‐kuraishy, Mahmoud E. Youssef, Kareem Morsy, Mohammed A. AlShehri, Simona Cavalu and Gaber El‐Saber Batiha and has published in prestigious journals such as PLoS ONE, The FASEB Journal and International Journal of Molecular Sciences.

In The Last Decade

Rabab S. Hamad

44 papers receiving 353 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rabab S. Hamad Egypt	11	120	44	38	36	33	52	357
Nicoleta Andreescu Romania	12	163 1.4×	42 1.0×	29 0.8×	22 0.6×	35 1.1×	81	450
Chunlan Yang China	14	162 1.4×	35 0.8×	21 0.6×	34 0.9×	31 0.9×	25	445
Shuping Zhong China	15	208 1.7×	49 1.1×	25 0.7×	35 1.0×	24 0.7×	28	563
Wen‐Li Hsu Taiwan	11	88 0.7×	20 0.5×	35 0.9×	24 0.7×	24 0.7×	31	340
Wang-xian Tang China	9	207 1.7×	39 0.9×	31 0.8×	65 1.8×	21 0.6×	25	521
Asmaa Mohammed ShamsEldeen Egypt	13	133 1.1×	39 0.9×	53 1.4×	50 1.4×	12 0.4×	47	441
Gaber El-Saber Batiha Egypt	8	93 0.8×	17 0.4×	28 0.7×	32 0.9×	23 0.7×	25	308
Tatiana Bandaletova United Kingdom	13	79 0.7×	27 0.6×	80 2.1×	26 0.7×	75 2.3×	16	373
Xiaohan Li China	12	126 1.1×	43 1.0×	67 1.8×	46 1.3×	70 2.1×	36	419
Yen-Chang Chen Taiwan	7	106 0.9×	15 0.3×	26 0.7×	16 0.4×	11 0.3×	12	317

Countries citing papers authored by Rabab S. Hamad

Since Specialization

Citations

This map shows the geographic impact of Rabab S. Hamad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rabab S. Hamad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rabab S. Hamad more than expected).

Fields of papers citing papers by Rabab S. Hamad

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rabab S. Hamad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rabab S. Hamad. The network helps show where Rabab S. Hamad may publish in the future.

Co-authorship network of co-authors of Rabab S. Hamad

This figure shows the co-authorship network connecting the top 25 collaborators of Rabab S. Hamad. A scholar is included among the top collaborators of Rabab S. Hamad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rabab S. Hamad. Rabab S. Hamad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hamad, Rabab S., Elsayed A. Elmorsy, Mahmoud A. Abdelaziz, et al.. (2025). Sirtuin 6-driven ASC deacetylation confers hepatoprotection: A promising approach to inflammasome inhibition in experimental NASH. European Journal of Pharmacology. 1006. 178202–178202. 1 indexed citations

Saber, Sameh, Zubida M. Al‐Majdoub, Rabab S. Hamad, et al.. (2025). Modulation of FOXO3a Nuclear Localization by Linagliptin (BI-1356) reveals a new therapeutic target in chronic ulcerative colitis. European Journal of Pharmaceutical Sciences. 209. 107100–107100. 3 indexed citations

Hamad, Rabab S., Sameh Saber, Amel Ahmed, et al.. (2025). Dual-sensitive gelatin-coated chitosan microparticles for targeted semaglutide pulmonary delivery: a novel approach to enhancing anti-inflammatory and anti-fibrotic effects. International Immunopharmacology. 165. 115480–115480.

Elmorsy, Elsayed A., Manal Mohamed Kamal, Rabab S. Hamad, et al.. (2025). Activation of nicotinamide phosphoribosyltransferase protects against unilateral renal ischemia-reperfusion injury via the NAD+/SIRT1/PGC-1α signaling pathway and modulation of NFκB/TNF-α/IL-6. European Journal of Pharmaceutical Sciences. 214. 107302–107302.

Cavalu, Simona, Rabab S. Hamad, Mustafa Ahmed Abdel‐Reheim, et al.. (2025). Localized Drug Delivery in Different Gastrointestinal Cancers: Navigating Challenges and Advancing Nanotechnological Solutions. International Journal of Nanomedicine. Volume 20. 741–770. 7 indexed citations

Doghish, Ahmed S., et al.. (2025). Phage therapy and its role in cancer treatment and control. Folia Microbiologica. 70(5). 941–960. 1 indexed citations

Hamad, Rabab S., Elsayed A. Elmorsy, Mahmoud A. Abdelaziz, et al.. (2025). AGK2 and nicotinamide riboside reveal SIRT2's protective role in a diabetic–dietary rat model of NASH via deacetylation of NLRP3, LKB1, and FOXO3a and restoration of AMPK–ACC/PGC-1α–Nrf2 signaling. International Immunopharmacology. 168(Pt 2). 115852–115852. 1 indexed citations

Abdelhamid, A. M., Sameh Saber, Rabab S. Hamad, et al.. (2024). STA-9090 in combination with a statin exerts enhanced protective effects in rats fed a high-fat diet and exposed to diethylnitrosamine and thioacetamide. Frontiers in Pharmacology. 15. 1454829–1454829. 4 indexed citations

Elmorsy, Elsayed A., Sameh Saber, Rabab S. Hamad, et al.. (2024). Modulating the HSP90 control over NFκB/NLRP3/Caspase-1 axis is a new therapeutic target in the management of liver fibrosis: Insights into the role of TAS-116 (Pimitespib). Life Sciences. 354. 122966–122966. 7 indexed citations

10.

Elmorsy, Elsayed A., Rabab S. Hamad, Mustafa Ahmed Abdel‐Reheim, et al.. (2024). Nicardipine-chitosan nanoparticles alleviate thioacetamide-induced acute liver injury by targeting NFκB/NLRP3/IL-1β signaling in rats: Unraveling new roles beyond calcium channel blocking. International Immunopharmacology. 141. 113000–113000. 6 indexed citations

11.

Hamad, Rabab S., et al.. (2024). Diagnosis Dilemma of Fibroblastic Osteosarcoma: A Case Report. Cureus. 16(11). e74093–e74093. 1 indexed citations

12.

Mohammed, Osama A., Ahmed S. Doghish, Rabab S. Hamad, et al.. (2024). Linagliptin, a DPP ‐4 inhibitor, activates AMPK / FOXO3a and suppresses NFκB to mitigate the debilitating effects of diethylnitrosamine exposure in rat liver: Novel mechanistic insights. The FASEB Journal. 38(4). e23480–e23480. 5 indexed citations

13.

Elmorsy, Elsayed A., Sameh Saber, Rabab S. Hamad, et al.. (2024). Advances in understanding cisplatin-induced toxicity: Molecular mechanisms and protective strategies. European Journal of Pharmaceutical Sciences. 203. 106939–106939. 40 indexed citations

14.

Saber, Sameh, Elsayed A. Elmorsy, Rabab S. Hamad, et al.. (2024). PU-H71 (NSC 750424): a molecular masterpiece that targets HSP90 in cancer and beyond. Frontiers in Pharmacology. 15. 1475998–1475998. 3 indexed citations

15.

Cavalu, Simona, Sameh Saber, Rabab S. Hamad, et al.. (2024). Orexins in apoptosis: a dual regulatory role. Frontiers in Cellular Neuroscience. 18. 1336145–1336145. 3 indexed citations

16.

Ali, Naif H., Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.. (2023). Role of brain renin–angiotensin system in depression: A new perspective. CNS Neuroscience & Therapeutics. 30(4). e14525–e14525. 27 indexed citations

17.

Al‐kuraishy, Hayder M., Ali I. Al‐Gareeb, Luay Alkazmi, et al.. (2023). The Potential Nexus between Helminths and SARS-CoV-2 Infection: A Literature Review. Journal of Immunology Research. 2023. 1–14. 4 indexed citations

18.

Hamad, Rabab S., Hayder M. Al‐kuraishy, Αθανάσιος Αλεξίου, et al.. (2023). SARS-CoV-2 infection and dysregulation of nuclear factor erythroid-2-related factor 2 (Nrf2) pathway. Cell Stress and Chaperones. 28(6). 657–673. 13 indexed citations

19.

Hamad, Rabab S.. (2023). Rutin, a Flavonoid Compound Derived from Garlic, as a Potential Immunomodulatory and Anti-Inflammatory Agent against Murine Schistosomiasis mansoni. Nutrients. 15(5). 1206–1206. 13 indexed citations

20.

Hamad, Rabab S., et al.. (2017). Advantages of bioconjugated silica-coated nanoparticles as an innovative diagnosis for human toxoplasmosis. Acta Tropica. 177. 19–24. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact